Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Enliven Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- −6 vs. Q3 2025
- Shares held
- 62.4M
- +3.00M (+5.0%) vs. Q3 2025
- Total value
- $960.9M
- −$254.7M (−21.0%) vs. Q3 2025
- New holders
- 20
- 46 more added
- Sold out
- 26
- 45 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quantbot Technologies LP | 1,770 | $27.3K | 0.00% | −376−17.5% | Reduced |
| Amalgamated Bank | 1,237 | $19.0K | 0.00% | +19+1.6% | Added |
| Royal Bank of Canada | 1,219 | $18.0K | 0.00% | −33,853−96.5% | Reduced |
| GF Fund Management Co. Ltd. | 1,165 | $17.9K | 0.00% | −109−8.6% | Reduced |
| Caitong International Asset Management Co., Ltd | 940 | $14.5K | 0.00% | +932+11,650.0% | Added |
| Farther Finance Advisors, LLC | 688 | $10.6K | 0.00% | +682+11,366.7% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 635 | $10.0K | 0.00% | +158+33.1% | Added |
| Nisa Investment Advisors, LLC | 589 | $9.07K | 0.00% | −27−4.4% | Reduced |
| Quadrant Capital Group LLC | 295 | $4.54K | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 279 | $4.30K | 0.00% | +177+173.5% | Added |
| Versant Capital Management, Inc | 212 | $3.27K | 0.00% | −333−61.1% | Reduced |
| GAMMA Investing LLC | 190 | $2.93K | 0.00% | −12−5.9% | Reduced |
| SRS Capital Advisors, Inc. | 137 | $2.11K | 0.00% | −16−10.5% | Reduced |
| Daiwa Securities Group Inc. | 152 | $2.00K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 106 | $1.63K | 0.00% | −13−10.9% | Reduced |
| Massmutual Trust Co FSB | 100 | $1.54K | 0.00% | +30+42.9% | Added |
| CWM, LLC | 94 | $1.00K | 0.00% | −18−16.1% | Reduced |
| Optiver Holding B.V. | 64 | $986 | 0.00% | −44−40.7% | Reduced |
| Advisor Group Holdings, Inc. | 60 | $924 | 0.00% | −25−29.4% | Reduced |
| Cornerstone Financial Management LLC | 42 | $647 | 0.00% | +42 | New |
| SBI Securities Co., Ltd. | 37 | $570 | 0.00% | −1−2.6% | Reduced |
| Signaturefd, LLC | 26 | $400 | 0.00% | −21−44.7% | Reduced |
| The PNC Financial Services Group, Inc. | 22 | $339 | 0.00% | +3+15.8% | Added |
| Rothschild Investment LLC | 20 | $308 | 0.00% | −25−55.6% | Reduced |
| Smartleaf Asset Management LLC | 1 | $16 | 0.00% | +1 | New |
| Covestor Ltd | 6 | $0 | 0.00% | −11−64.7% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −947,405−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −783,411−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −156,463−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −73,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −59,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −50,492−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −40,314−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −40,314−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −31,438−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −27,518−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −16,458−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −13,371−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −13,097−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −10,811−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −10,675−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −3,181−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −491−100.0% | Sold out |
| ORG Partners LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |